A doctor might recommend adding rapid insulin before a meal to prevent a blood sugar spike after you eat. If you change brands of long-acting insulin, you may need a different dose. Talk to a ...

It is the first biosimilar of a rapid-acting insulin product – used to ... While a few years ago, the loss of patent protection for a big insulin brand would have been a deal for Novo Nordisk ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin ... effective alternatives to brand name drugs approved through ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls the new drug “Merilog,” a biosimilar to the widely-used insulin ...

Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Merilog helps to lower mealtime blood sugar ...

The global rapid acting insulin market was valued at $7,100 million in 2019, and is projected to reach $8,925 million by 2027 at a CAGR of 4.1% from 2020 to 2027. The growth of the global rapid acting ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c at 30 weeks for adults with type 1 diabetes, according to findings from ...

AID systems are beneficial for individuals with both type 1 and type 2 diabetes who require multiple daily injections of ...